CARETRUST REIT INC (CTRE)
Real Estate · healthcare REIT · NYSE
A specialized REIT focused on acquiring and leasing skilled nursing and assisted living facilities to healthcare operators.
What CARETRUST REIT INC does
CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust that acquires, manages, and finances healthcare-related real estate. Its portfolio consists primarily of skilled nursing facilities (SNFs), assisted living facilities (ALFs), and other healthcare-related properties leased to experienced regional and local operators.
Themes: healthcare infrastructure, aging population, skilled nursing care, assisted living real estate, real estate investment trust (REIT)
Fundamentals
- Price$39.58 as of 2026-08-21 close
- Market cap$9.4B as of 2026-08-21
- 1-year return+14.6% 2025-08-21 close $34.54 → 2026-08-21 close $39.58
- P/E25.82 as of 2026-08-24
- Net margin+62.2% as of 2026-08-24
- Gross margin+98.8% as of 2026-08-24
- ROE+8.5% as of 2026-08-24
- Debt / equity0.27 as of 2026-08-24
- Revenue growth (YoY)+53.0% as of 2026-08-24
- Revenue CAGR (3y)+34.4% SEC XBRL
- Beta0.78 as of 2026-08-24
- Last reported earnings2026-08-06 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +4.9%; at least 5 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How CTRE compares in its sector
- price-to-earnings ratiomiddle range 127 covered Real Estate peers, as of 2026-08-24
- net profit margintop 10% 161 covered Real Estate peers, as of 2026-08-24
- operating margintop 10% 161 covered Real Estate peers, as of 2026-08-24
- gross margintop 10% 156 covered Real Estate peers, as of 2026-08-24
- return on equitymiddle range 162 covered Real Estate peers, as of 2026-08-24
- 3-year revenue CAGRtop 10% 155 covered Real Estate peers
- indicated dividend yieldmiddle range 138 covered Real Estate peers, as of 2026-08-24
Position among covered Real Estate companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
CTRE is in the Real Estate Long-term Top 10.
Real Estate Long-term Top 10 — since 18 Aug 2026
Long-term score
70.4 #35 of 987 scored · #2 of 84 in Real Estate
Growth 98th (revenue growth year over year 53%, 3-year revenue CAGR 34.4%) and financial health 77th (debt to equity 0.3); weakest is long-term trend (52nd, a trend forming but not yet strong (ADX below 25)).
Short-term score
44.2 #1176 of 1,704 scored · #53 of 94 in Real Estate
Volume and participation 88th: trading volume is about normal versus its 30-day average; trend 47th: a "golden cross" — its 50-day average is above its 200-day; weakest is catalysts 27th: the analyst consensus rating has softened toward "sell" since the prior reading.
In this list since 18 Aug 2026 — currently 2nd in the list (3 days)
- Entered 18 Aug 2026: first selection for this list at rank 2, score 68.8.
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, CTRE's dividend was covered by reported results (earnings payout 81%, operating-cash-flow payout 66%). This describes past coverage, not a forecast.
- Earnings payout81% dividends / net income
- Operating-cash-flow payout66% dividends / operating cash flow — capital spending was not reported, so this does not subtract it
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How CARETRUST REIT INC looks technically
CARETRUST REIT INC (CTRE) is trading 2.0% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 293 trading days ago — a "golden cross", a bullish long-term signal. A trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 21 (a reading of 25+ marks a strong trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 43, neither overbought (above 70) nor oversold (below 30). It made a new 20-day low about 9 trading days ago.
Trend
7
| Distance from the 200-day | it is trading 2.0% above its 200-day average, the long-term trend line — a longer-term uptrend | +2.0% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $40.34 | $40.34 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $38.79 | $38.79 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing low 7 calendar days ago — the swings before that are what the structure reading is measured on | 7 sessions |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 293 trading days ago — a "golden cross", a bullish long-term signal | 293 sessions |
| Trend strength (14-day ADX) | a trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 21 (a reading of 25+ marks a strong trend) | 21.1 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 43, neither overbought (above 70) nor oversold (below 30) | 43.5 |
|---|---|---|
| Position in its 14-day range | it is trading in the lower half of its 14-day range ($37.98 to $41.58) — its "stochastic" reading is 44 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 44.4 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in negative territory (momentum leaning bearish) | 17 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $43.62 | $43.62 |
|---|---|---|
| From the 52-week high | it is 9.3% below its 52-week high (its highest price of the past year) | -9.3% |
| Above the 52-week low | it is 20.7% above its 52-week low (its lowest price of the past year) | +20.7% |
| Below the 52-week high | it is 9.3% below its highest point of the past year | 9.3% |
| Since a 20-day breakout | it made a new 20-day low about 9 trading days ago | 9 sessions |
| Since a 55-day breakout | it made a new 55-day high about 24 trading days ago | 24 sessions |
| All-time high | its highest closing price on record is $43.62 (set on 2026-07-28) | $43.62 |
| Given back of the 52-week move | over the past year its closes ranged ($32.90 to $43.40), and it has given back roughly a third of its rise from last year’s low — 36% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $36.58 to $36.91. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 36.4% |
| From the all-time high | it is 9.3% below its all-time high | -9.3% |
| Nearest price level | it is trading 1.1% below a resistance level at $40.02 — a price it turned at three times since 2026-04-16, most recently on 2026-07-15. Since 2024-08-21 it has 13 such levels below the current price and 4 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +1.1% |
| All-time low | its lowest closing price on record is $7.16 (set on 2020-03-18) | $7.16 |
| Above the all-time low | it is 452.8% above its all-time low | +452.8% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 53rd percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.9032 between its high and its low — about 2.3% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.9032 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $37.87 and $43.20 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $37.87 – $40.54 – $43.20 |
| Typical daily range (% of price) | its price moves about 2.3% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.3% |
| Stretch from the 200-day average | it is trading 0.9 daily ranges above its 200-day average price (2.0% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 0.9 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.32× |
|---|
Analyst
2
| Change in the average price target | analysts have raised their average price target by 0.2% since the prior reading | +0.2% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating has softened toward "sell" since the prior reading | 0.08 toward sell |
Candlestick patterns
1
| Since a doji | 1 session ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 1 session ago |
|---|
Price gaps
2
| Gap at the open | it opened on 2026-08-21 0.6% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.6% |
|---|---|---|
| Gap filled | a 2.9% gap up opened on 2026-06-11 has been "filled" 49 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 49 sessions ago |
Price streaks
1
| Closing streak | it has closed lower 2 sessions in a row, a -0.6% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 2 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 11.1 percentage points (the stock lost 8.8% while the market gained 2.3%) | -11.1% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 6.6 percentage points (the stock lost 3.5% while the market gained 3.1%) | -6.6% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 12.2 percentage points (the stock lost 1.2% while the market gained 11.1%) | -12.2% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 5.9 percentage points (the stock gained 14.6% while the market gained 20.5%) | -5.9% |
Signal agreement
2
| Bullish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average — these describe past price behaviour, not a forecast | 2 of 9 |
|---|---|---|
| Bearish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bearish state: MACD momentum is negative, lagging the market over 6 months — these describe past price behaviour, not a forecast | 2 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading inside the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the zone traders read as unresolved — neither side has established a trend, and the band is where that gets settled. The band itself is thin, spanning 1.4% of the share price, which is taken to mean a barrier that gives way easily. | 0.0% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 2% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $38.99 — a volume-weighted average of daily closes over 158 sessions, not a true tick-by-tick VWAP. | +1.5% |
|---|---|---|
| Vs the average paid since it last reported | the price is sitting right on the average price paid since it last reported on 2026-08-06 (its 10-Q), so the typical buyer over that stretch is roughly break-even. That average is $39.66 — a volume-weighted average of daily closes over 12 sessions, not a true tick-by-tick VWAP. | -0.2% |
Price levels it has turned at before
CTRE last closed at $39.58 on 2026-08-21. Since 2024-08-21 it has turned at 13 prices below its last close and 4 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $40.02 | Resistance | 1.1% above the last close | turned there three times · 2026-04-16 to 2026-07-15 |
| $38.38 | Support | 3.0% below the last close | turned there five times · 2025-12-04 to 2026-08-14 |
| $41.34 | Resistance | 4.5% above the last close | turned there three times · 2026-02-17 to 2026-03-13 |
| $37.05 | Support | 6.4% below the last close | turned there twice · 2025-11-10 to 2026-04-22 |
| $42.11 | Resistance | 6.4% above the last close | turned there twice · 2026-05-26 to 2026-07-07 |
| $35.82 | Support | 9.5% below the last close | turned there 7 times · 2025-10-03 to 2026-06-18 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · lagging the market · Trading at this year’s average price paid (anchored VWAP) · Trading inside the Ichimoku cloud · Near a resistance level (pressing into a price that has capped it before) | Learn: moving average · golden cross · adx · rsi · breakout
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.31 mean, 1=Strong Buy…5=Strong Sell) — 13 analysts
- Mean price target$45.38 range $43.00 – $49.00; median $45.00
Analyst estimates, as of 2026-08-19. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for CTRE
- Consensus EPS estimate$0.4325 next reporting period, as of 2026-08-19
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Dependence on third-party operators and their ability to operate successfully and pay rent.","Regulatory and legislative changes in the healthcare industry, particularly regarding government reimbursement programs like Medicare and Medicaid.","Risks associated with the concentration of properties in the skilled nursing and assisted living sectors."]
What changed in the latest 10-Q
AI-assisted comparison of CTRE's 10-Q filed 2026-05-07 against the prior one filed 2025-11-05.
Management's Discussion & Analysis (MD&A)
- Added:
- Added reference to 'managers' alongside 'tenants' and 'borrowers' in risk factor (i) regarding ability to perform obligations
- Added risk factor regarding 'additional operational and legal risks associated with our properties managed in a RIDEA (as defined below) structure' as item (x)
- Added description of RIDEA structure and SHOP (senior housing operating portfolio) establishment in fourth quarter 2025 with first acquisition in December 2025
- Added disclosure of three senior housing communities with 270 units in Texas operated under SHOP platform as of March 31, 2026
- Updated Overview section to reflect March 31, 2026 reporting date and removal of specific property type descriptions (no longer lists 'multi-service campuses, U.K. care homes, assisted living facilities, independent living facilities')
- Updated property count from 399 to 417 facilities and operational beds from 36,192 to 38,512
- Updated real estate secured loans from 15 to 17 and adjusted carrying values ($871.3 million to $931.5 million for other investments; $98.1 million to $92.5 million for financing receivable)
- Removed:
- Removed reference to 'tenants, managers, and borrowers' indemnification obligations language in older filing (item i) was replaced with expanded version that includes 'managers'
- Removed detailed description of Care REIT Acquisition closing on May 8, 2025 and Impact Health Partners LLP asset acquisition on June 30, 2025 (moved to 'Recent Developments - The Acquisition' section in older filing)
- Removed reference to 'declining consumer sentiment' from Market Trends and Uncertainties discussion
- Removed reference to 'significant COVID-19 outbreaks as well as other pandemics or epidemics' from public health crises risk factor
- Removed risk factor regarding 'potential liability relating to environmental matters and illiquidity of real estate investments'
- Removed reference to Form 10-K for year ended December 31, 2024 and Form 10-Q for quarter ended March 31, 2025; updated to Form 10-K for year ended December 31, 2025
- Reworded:
- Changed risk factor ordering and consolidation: older filing's item (i) regarding tenant obligations expanded to include 'managers' in newer filing
- Reordered risk factors: in older filing, impairment charges was item (ii), healthcare reform was item (iii); in newer filing, healthcare reform moved to item (iii), impairment charges in item (vi), with insertion of RIDEA risk as item (x)
- Changed 'seniors housing' to 'senior housing' in Overview section description
- Changed 'renew their leases' to 'renew their agreements' in risk factor language
- Added specification that tenants and managers must meet credit and operating standards in newer filing's item (viii)
- Reworded to specify 'managers who meet our credit and operating standards' alongside 'tenants' in acquisition ability risk factor
- Notes:
- The newer filing appears truncated at 'As a result of impacts experienced by our operators due to recent market trends and uncertainties, the ability of some of our tenants and b' - comparison may be incomplete for subsequent MD&A content
- The older filing's 'Recent Developments' section includes 'The Acquisition' subsection describing Care REIT acquisition details, which is not present in the newer filing's provided text (likely appears elsewhere in newer filing)
Risk Factors
The two filings could not be meaningfully compared for this section.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales are on record for CTRE — recent Form 4 activity was compensation-related (awards, option exercises, or tax withholding), not open-market buying or selling.
View full insider trading history → View SEC Form 3/4/5 filingsOnly open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Short interest (FINRA)
CTRE had 24,289,020 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
CTRE had 10.3% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 11.37 days to cover at the same settlement.
- Reported short interest (shares) 24,289,020
- Short interest (% of shares outstanding) 10.3%
- Prior settlement (shares) 23,841,757
- Reported change 1.88%
- Days to cover (reported) 11.37
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Omega Healthcare Investors (OHI)
- Welltower (WELL)
- Ventas (VTR)
- Sabra Health Care REIT (SBRA)
- National Health Investors (NHI)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare CTRE vs…
CARETRUST REIT INC is found in…
Frequently asked questions
What does CARETRUST REIT INC (CTRE) do?
CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust that acquires, manages, and finances healthcare-related real estate. Its portfolio consists primarily of skilled nursing facilities (SNFs), assisted living facilities (ALFs), and other healthcare-related properties leased to experienced regional and local operators.
What sector is CARETRUST REIT INC (CTRE) in?
CARETRUST REIT INC (CTRE) is classified in the Real Estate sector. Its industry is healthcare REIT. It trades on NYSE.
Does CTRE pay a dividend?
Yes — CARETRUST REIT INC (CTRE) pays a dividend, with an indicated yield of about 4.85% and at least 5 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-08-24). Informational only — not financial advice.
Who are CARETRUST REIT INC's (CTRE) competitors?
Notable peers of CARETRUST REIT INC (CTRE) include Omega Healthcare Investors, Welltower, Ventas, Sabra Health Care REIT and National Health Investors. This peer set is informational only — not financial advice.
Is CARETRUST REIT INC (CTRE) overbought or oversold right now?
CARETRUST REIT INC (CTRE) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 43, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on CTRE come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.